Aller au contenu principal
Accès ouvert déclaré 2023 preprint

"Modulating Cancer Cell Cycle: Arresting and Shifting Rapid Dividing Cells to G0 Phase": A Review Article (Preprint)

0Citations signalées — pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Résumé fourni par la source

UNSTRUCTURED In the rigid battle against cancer, an innovative strategy has emerged, one that seeks to harness the details of the cancer cell cycle to control its relentless growth. This review boards on a thorough exploration of the current landscape by studying the literature, aiming to shed light on manipulating cancer cells' division through the induction of a pause or rapid transition into the G0 phase. By meticulously evaluating existing studies, the authors navigate through various aspects, including the examination of malignant cells in early stages, clinical trials involving G0 phase-targeting chemotherapy, and the modulation of cell signaling mechanisms pivotal to the cell cycle. With a systematic approach, the investigation unfolds through in vitro experimentation and escalates into in vivo assessment, providing a comprehensive understanding of the subject matter. Crossing over the curve of the past five decades, this review dissects the trends in research, highlighting the evolution of insights into the complexities of the cancer cell cycle. However, among the endeavors to unravel its complexities, significant gaps and limitations remain. These gaps encompass the insufficient documentation of ontogeny, proto-oncogenes, and the complex process of carcinogenesis, evidence of the multifaceted challenges that persist in this field.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
"Modulating Cancer Cell Cycle: Arresting and Shifting Rapid Dividing Cells to G0 Phase": A Review Article (Preprint)
Date Crossref
05/10/2023
Éditeur
JMIR Publications Inc.
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Sujets associés

Cancer Research and TreatmentsCancer-related Molecular PathwaysCancer Cells and Metastasis

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.